Quotient: Q1 Earnings Insights

Shares of Quotient QTNT remained unaffected after the company reported Q1 results.

Quarterly Results

Earnings per share were up 11.11% year over year to ($0.32), which beat the estimate of ($0.33).

Revenue of $8,924,000 higher by 9.24% from the same period last year, which beat the estimate of $8,670,000.

Outlook

Quotient hasn't issued any earnings guidance for the time being.

The upcoming fiscal year's revenue expected to be between $32,000,000 and $34,000,000.

How To Listen To The Conference Call

Date: Aug 03, 2020

Time: 08:00 AM

ET Webcast URL: http://public.viavid.com/player/index.php?id=140047

Recent Stock Performance

52-week high: $11.30

Company's 52-week low was at $2.40

Price action over last quarter: Up 7.03%

Company Description

Quotient Ltd is a commercial-stage diagnostics company. It is involved in the business of provision of tests with an initial focus on blood grouping and serological disease screening. The company develops and commercializes Mosaiq automation platform. Its product portfolio includes Red cell reagents, Antisera, Specialty products, Specialty kits etc. The firm operates in Edinburgh, Scotland, Eysins, Switzerland and Newton, Pennsylvania. It derives the majority of its revenue from the United States.